This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: University of Pennsylvania, University of Florida Research Foundation Inc.. Active years: 2016-2022.
Company Filing History:


Years Active: 2016-2022
Title: Jon Lindstrom: Innovator in Immunosuppressive Compositions
Introduction
Jon Lindstrom is a notable inventor based in Radnor, PA (US). He has made significant contributions to the field of immunology, particularly in the development of treatments for myasthenia gravis. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Lindstrom's latest patents include innovative compositions and methods for treating myasthenia gravis. One of his notable inventions is a vaccine composition that comprises two or three acetylcholine receptor (AChR) subunit constructs along with an adjuvant. This composition aims to enhance the immune response in patients suffering from this condition. Additionally, he has developed nicotine compounds and analogs, which include methods of synthesis and treatment applications. These compounds are designed to selectively stimulate specific receptors, offering new avenues for therapeutic interventions.
Career Highlights
Throughout his career, Jon Lindstrom has worked with prestigious institutions such as the University of Pennsylvania and the University of Florida Research Foundation Inc. His research has focused on advancing the understanding and treatment of neuromuscular disorders, showcasing his commitment to improving patient outcomes.
Collaborations
Lindstrom has collaborated with esteemed colleagues, including William Reade Kem and Jie Luo. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Jon Lindstrom's contributions to the field of immunology through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of myasthenia gravis and related conditions.